Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Melanoma treatment details. Immunotherapy. University of Medical Sciences , Poznan , Poland



Survival: 17.3 months
   
Toxicity Grade: 2
   
Treatments: Immunotherapy
   
Drugs:
Country: Poland
   
City/State/Province: Poznan
   
Hospital: University of Medical Sciences
   
Journal: Link
   
Date: 5/2015

Description:
Patients:
This phase 2 study involved 77 advanced melanoma patients with an average age of 51.7 years; 48% were male.

Treatment:
Patients received immunotherapy with a melanoma vaccine called AGI-101H, which is composed of human allogeneic (not identical to the patient) cells that are meant to direct the immune system to attack cancer cells.

Toxicities:
The most severe toxicities were of grade 2 and included fever, sweating, and injection site reactions.

Results:
The median overall survival was 17.3 months.

Correspondence: Dr. Jacek Mackiewicz; email: jmackiewicz@ump.edu.pl

E-mail to a Friend Email Physician More Information